Episode #229: Supportive Oligonucleotide Therapy (SOT) with Dr. Clayton Bell, MD
In a Nutshell
Dr. Clayton Bell, an integrative MD who recovered from Lyme and co-infections using Supportive Oligonucleotide Therapy (SOT, now Q Restrain from RGCC), reports ~85% clinical success in 300+ Lyme/Bartonella/Babesia/viral cases, with personalized antisense oligonucleotides silencing pathogen mRNA to reduce bacterial/viral loads without eradication. Prioritize direct tests (PCR/FISH) over antibodies for targeting (e.g., top: Borrelia burgdorferi), prep with mold detox and Herx support, administer IV every 3+ weeks ($2,200–$3,500 each), avoid antimicrobials 2 weeks pre/post, and retest after 6 months. Contraindicated in pregnancy, advanced neurodegeneration, or large tumors; combine with herbals/antibiotics for best outcomes in resilient patients.
These notes were generated by AI and may contain inaccuracies.
Episode #229: Supportive Oligonucleotide Therapy (SOT) with Dr. Clayton Bell, MD
Welcome to Better Health Guy blogcasts, empowering your better health. The content of this show is for informational purposes only and is not intended to diagnose, treat, or cure any illness or medical condition. Nothing in today's discussion is meant to serve as medical advice or as information to facilitate self-treatment. As always, please discuss any potential health related decisions with your own personal medical authority.
Hello everyone and welcome to episode 229 of the Better Health Guy blog series. Today's guest is Dr. Clayton Bell and the topic of the show is supportive oligonucleotide therapy or SOT, recently renamed to Q restrain. Dr. Clayton Bell is a leading integrative and functional medicine physician dedicated to helping patients achieve deep lasting wellness. Dr. Bell works with Lyme and vector-borne infections, integrative cancer support, environmental medicine, including mold, mycotoxins, heavy metals, and detoxification, hormones, cardiometabolic and GI health, and mind body balance. Combining his western medical training with functional, integrative, environmental, and aurorhetic approaches, he focuses on uncovering the root causes of health concerns. Patients benefit from personalized whole-person treatment plans that empower the body's natural healing ability and support sustainable wellness from the inside out. Dr. Bell provides online consultations that offer accessible holistic care tailored to each individual's needs.
I am very excited today to have Dr. Clayton Bell on the podcast to talk about supportive oligonucleotide therapy, also known as SOT, recently renamed to Q restrain. This is a therapy for the last several years that I've had questions about where it fits into the landscape of healing. As I had the opportunity to dig a little deeper for this conversation, I became more excited to learn about this as another potentially valuable tool in our toolbox.
I'm so happy to be here. Yeah, thank you for having me.
Dr. Bell's background: Functional medicine landscape has always been more aligned with my philosophical and medical value system. Even in medical school, looking for deeper root cause analysis and deeper forms of healing. Getting into SOT therapies or Cure Strain (now called by RGCC) was due to getting Lyme disease myself. Highly functional through medical school, fellowship in integrated medicine at University of Kansas, working at University of Tennessee Medical Center doing functional medicine consultations for the cancer institute. Had internal health issues: adrenal hyperactivity dysfunction, excess cortisol, extremely low testosterone (in the 100s, lower than most 80-year-old men), borderline osteoporosis by age 30 despite being athletic mountain biker, hypothyroid, lost 40 pounds during first year of residency (thought due to stress, sleep deprivation, going vegetarian). Realized got Lyme that year in Maine. Explained HPA axis and adrenal dysfunction, low testosterone—nothing helped despite meditation, clean eating, self-care. There was an internal challenge stressor: not only Borrelia burgdorferi Lyme, but first Vibrant Wellness tick panel lit up like a Christmas tree—at least six different forms of Borrelia, multiple forms of Bartonella and Babesia.
Treated with antibiotics, herbals, then SOTs got him over the hump. About 8 months into therapy, things clicked: put on 10 pounds of muscle, then another 10, thyroid regulated, not cold all the time, testosterone autoregulated without TRT or hormone replacement, stress levels down, felt more embodied and healthier. Didn't realize he'd been sick for a decade—it was so slow and continuous he thought it was normal. Getting healthier brought new awareness of brain fog, low energy, poor mood.
Oh my god, wow. I've been having a lot of brain fog and I haven't had as much energy and my mood has not been as good.
Motivated to help others. In Asheville, western North Carolina, tested over 300 people—exception of one or two, all have immune signatures of exposure to Lyme, Bartonella, Babesia, maybe Ehrlichia, Anaplasma, Rickettsia, and mold, mycotoxins. These are ubiquitous in environment; we all carry some, some more than others, some sicker at different times. Personal passion because best research is knee search. Tested wife, mom, dad—they have it. Daughter (age 6) had bullseye rash last summer. Hundreds of patients actively treating. Shifted focus: 90+% of practice now Lyme, mold (by proxy, many Lyme patients have mold), personalized cancer testing and therapies.
Pain to passion story. SOT (what we'll refer to it as), now Q restrain, technology from RGCC in Cyprus, Greece. Much of earlier work known in cancer realm—not focus today. Focus on newer tools for Lyme, co-infections, viruses.
Why need for SOT in toolbox, where it fits for vector-borne illness patients, how long used, how many patients, clinical success. Been in Lyme co-infection mold realm over two decades—high success percentages raise questions if marketing or reality.
Fit into treatment: First, diagnosis. For vector-borne like Lyme, Bart, Babesia, co-infections (rarely just one). Stratify based on condition, desires, belief system, resources.
- Antibiotics opposed (bad past experiences, GI dysfunction, allergies): No-go. For Bartonella: Bactrim or rifampin for 3 months. Babesia: Malaron + Zithro for 3 months. Lyme recent: couple months doxy + herbs. Chronic Lyme: tough, need 3 antibiotics for spirochete, cell wall deficient, cyst forms—prefer not to do 3 antibiotics multiple months.
- Antibiotics effective, life-rejuvenating for many.
- Herbals: Buhner protocol, others—cryptolepis, Japanese knotweed, skullcap, host of others. Use across board adjunctively with every patient (SOT or antibiotics). More effective in combination. Sometimes all patients do if can't afford SOT or no antibiotics.
SOTs (for vector-borne and viral infections): If free, give to all patients—very safe. Only worry: Herx reactions. In cancer: different, specific contraindications (tumor mass 5cm+ cumulative, brain/lungs/liver—can cause edema, mass effect, pulmonary edema, liver issues, tumor lysis syndrome). Not option for advanced cancers.
For Lyme/viruses: very safe. Herx reactions similar to antibiotics/herbals/biofilm busters. Mitigate Herx to maximize success.
They're very effective... relatively speaking compared to what I've seen with herbals and antibiotics.
Not 100% effective, not panacea. Won't wipe out every spirochete Borrelia. Philosophy: once have Borrelia burgdorferi, Bartonella henselae, Babesia, always have them forever—that's okay. Goal not eradication (like eradicating every speck of dust destroys house). Knock down pathogenic/allostatic load so immune system keeps at bay—like weed in garden among flowers.
Nuances: Cautious with advanced neurodegenerative (low resiliency, potential neuroinflammation die-off; seen temporary worsening couple months before leveling—scary, avoid in advanced). For 95% with active infection, give SOTs.
As RGCC provider, gets medicine for self/family—company generous to providers to encourage advocacy.
Personal use: 12 SOTs himself, wife 5, another being made now (positive Borrelia mayonii; wife PCR+ Borrelia mayonii, Borrelia afzelii—swapping sexually). Mom: every 6 months for cancer (NED post-allopathic, but 10,000 circulating tumor cells; test CPCs, SOT to mop up, prevent recurrence).
Resource game limits use for all patients.
Approximately 300+ SOTs: Started MetaMed November 2024 (1-16 months in: 110 patients). Previously Form Health Asheville ~4 years (used SOTs ~4 years collectively, ~3.5 years there: ~200). ~100-120 cancer, ~200+ mainly Lyme, Bartonella, Babesia, some viral.
Success rates: Two papers on SOTs specifically; thousands on anti-sense technology, gene silencing (≥10 FDA-approved drugs). One internal paper on Lyme/viral. Large studies costly, pharma-funded. RGCC (Dr. Giannis) data-driven, collecting data. Confounding variables in Lyme (co-infections, antibiotics/herbals, mold, etc.).
Clinically: ~85% success rate (85/100 notice significant difference 1-3 months post-SOT; some multiples). Not 85% symptom improvement (e.g., MSQ/Horowitz score 100 to 15), but clinical benefit. 15% flat (wrong pathogen, not main driver, undiagnosed mold/CIRS/MCAS—clean bacteria but no symptom improvement without neuro/immune reset).
Rare worsening: advanced Parkinson's, ALS (worse few months, back to baseline; some better—but deters use). Vast majority: benefit (life-changing: pain gone, no headaches/night sweats, function/work; or subtle). Depends on pathogens, therapies, priming (mold check, detox, methylation, vitamin D, trauma, autoimmune).
SOT amazing but need all other things for effectiveness. Explains variance in Facebook/social media (strong advocates/detractors)—nuances/intangibles. SOT technology sound.
AOT/anti-sense oligonucleotide therapy underlying technology/framework; SOT application to patients.
Suggest visual: 2-minute cartoon videos on transcription/translation (DNA-RNA-proteins). Anti-sense technologies: messenger RNA silencing therapies.
Metaphor: COVID mRNA vaccines insert mRNA to create spike protein for immune response. SOTs opposite: introduce silencing mRNA to block protein production (prevent spike protein creation). Geared to specific genus/species (e.g., positive test from IGeneX, Vibrant, LabCorp for Borrelia).
For instance, a positive test from IGeneX, Vibrant, or LabCorp for Borrelia burgdorferi. Send blood to the lab in Greece; they isolate the organism via PCR using spot testing technology from sister company Bioenter. They sequence the genome, noting 32 different plasmids with genetic interchanges. Borrelia today differs from two years from now due to environmental genetic expression. They analyze at DNA, mRNA levels to create a nucleotide sequence, the essence of the antisense technology.
DNA is a double helix; RNA polymerase splits it, RNA attaches and replicates with base changes, forming mRNA. mRNA attaches to ribosomes in endoplasmic reticulum or cytoplasm, producing amino acids that build proteins for metabolism, reproduction, replication. Silencing mRNA targets specific mRNA sequence like a glove on a hand or jigsaw puzzle piece, attaching and degrading it—like birth control preventing reproduction or a knockout gene. Tested in silico and in a dish before sending; reconfigured if ineffective. Ensures specificity as many misidentify pathogens (e.g., different species in same genus).
Analogy: Pac-Man—attaches specifically, inert without the pathogen's mRNA sequence, no damage to host cells. > "Birth control for bugs."
Positive test required at genus and species level with available SOT. RGCC accepts blood serum tests (not urine, e.g., no longer DNA Connections urine PCR—hypothesized due to positives not found in blood, leading to refunds and labor costs). Accepts blood tests within 6 months: Quest/LabCorp Western Blot (even if patient can't afford better), PCR, IgM/IgG (e.g., one moderately positive IgG band on Vibrant). Direct tests like FISH or PCR increase success; rarely can't find (2-3 times, including speaker's case—refunded, building trust).
Order via RGCC portal specifying genus/species (e.g., not just Lyme: B. burgdorferi, B. mayonii, B. californiensis; Bartonella henselae, B. quintana; Babesia duncani, B. microti).
IGeneX: Favorite for Medicare (TBD 6 IBL panel ~$2,700, free for 65+). FISH positive for Bartonella/Babesia often with negative/ indeterminate antibody; cross-orders with Vibrant Tick 1.0 for under-65 cash pay + IGeneX Bartonella/Babesia FISH if high risk. Vibrant great for Borrelia antibodies but misses/undersells Bartonella/Babesia. FISH+ / antibody- indicates severe infection (pathogen evading antibodies, free-floating).
If FISH+ without speciation, order Bartonella species or Babesia species SOT—RGCC PCRs and finds it (species doesn't matter clinically).
Vibrant PCR low sensitivity (<5 positives in 200-300 panels): positive = treat; negative = meaningless (like ELISA/Western Blot).
Poly Spot (> $1,000, fewer pathogens than Vibrant); Prime Spot (viruses too, ~$2,500 total)—cost-prohibitive if prioritizing SOT. Speaker uses on self every 6-12 months (recent positive). Vibrant gives many positives needing discernment (active vs. immunological memory).
RGCC PCR by spin cycles: fewer cycles = higher load (exponential: 10^10). Go to 35 cycles max—if sub-threshold, not clinically relevant (like THC urine threshold). Vibrant more sensitive (less specific)—use for antibody to trigger deeper RGCC spins (to 40 cycles).
LabCorp/Quest Western Blot low sensitivity (<50%), mainly B. burgdorferi (not 20+ species like Vibrant/IGeneX); used only for cheap recent positive. Also uses Armen Labs, T-Detect occasionally.
Bioenter Prime Spot: 14 viruses, 16 cytokines/ILs, 1 Lyme marker—not deep. Poly Spot: 19 Borrelia, 3 Bartonella, 2 Babesia (e.g., no B. quintana)—yet RGCC confirms non-listed pathogens; internal methods broader (defer to Dr. Terry Bomb).
Species-specific (e.g., 4 Bartonella = 4 SOTs; no genus-level or multi-organism due to specificity: 10-15 base pairs, 500K-1M sequences per vial—too much load). Previously weekly, now min 3 weeks apart; speaker uses monthly, delays for herxing. Shelf-stable 6 months; 1-3 at a time, flexible scheduling.
Determining organism: Vibrant example—10-12 IgG+ (relevant with symptoms; IgG > IgM despite vector-borne nuances). Prioritize direct (PCR/FISH) over antibodies. Intensity matters (Vibrant yellow/red, numerical). Road map for multiple SOTs over time.
Direct test positives like FISH or PCR are most preferential for SOT. Patients may have four or five positives but can only get one to three SOTs, so prioritize the most important. Number one: FISH or PCR positive. Number two: number of bands and magnitude of bands, prioritizing IgM over IgG if all else equal, even for chronic IgG infections. Then consider amplitude; e.g., if Brillia azellii on Vibrant has IgG/IgM of 25 and BL californiaris has 13, choose azellii. For Lyme, Vibrant may show a dozen bands with 3-7 lighting up; B. zellii gets 3-4 bands, M. merita or California one band. Multiple positive bands favor that pathogen.
Symptom clusters also guide choice; e.g., tick bite followed by panic attacks, shortness of breath, night sweats indicates Babesia SOT even with minimal lab positives due to clear constellation. Most cases are smudgy with multiple infections and mold, hard to tease out.
If five Borrelia positives, two Bartonella, two Babesia, and patient gets three SOTs, pick one from each genus. Rarely need multiple SOTs per genus; e.g., treat the most prevalent Bartonella based on labs, and retesting in six months shows both improve due to reduced immunological burden allowing immune system to attack others. Same for multiple Lyme species or EBV. Can do SOTs for viruses like HHV6 and EBV with good success, but addressing tick infections and mold often clears EBV as it's opportunistic. SOTs for viruses are like continual symptom management; focus on drivers allowing persistence.
Treating one Bartonella may create dead parts exposing overlaps within genus, waking immune system to sequestered species while less burdened.
Go after biggest infection first. Prep body upfront: check/treat mold first, as SOT alone insufficient with high mold load, leading to repeats or continued therapies. Start mitochondrial support, detoxification before first SOT.
Warn patients they might feel nothing (like cancer SOTs) or Herx; improvements may come in 1-3 months as symptoms lessen. Use Herxheimer Support by Allergy Research Group (barbar salts, curcumin, boswellia)—clinically helpful for SOTs, antibiotics like malaria, diflucan. For sensitive patients: Lipo glutathione, binders, Quercetin, Zyrtec (H1 blocker), Cromolyn, Kratom. Anti-inflammatories like curcumin, resolvins, omegas, boswellia for high inflammation, joint pain, HS-CRPs.
Personal anecdote: After first SOT, turned white as ghost from poor detox (GI/peristalsis issues from tick infections), constipated; coffee enemas every other day for weeks saved him, now as needed for major Herx/toxicity—cheapest, most effective, works immediately.
Herxheimer Support likely by Dr. Darren Les, good Alka-Seltzer Gold replacement (discontinued).
SOT gene sequence from patient's bug is personalized, even same genus/species. Every species in genus has different SOT target region? Possible overlaps, e.g., B. henselae affecting another Bartonella; bacteria like Lyme have plasmid exchange, Babesia less, Bartonella shares horizontally. Not bench-confirmed.
Organisms don't mutate much within one person but do over time/populations. Patient-specific target addresses potential mutations, more effective than off-shelf stacks.
Borrelia: 18-19 SOTs. Bartonella: 6. Babesia: 6. Also Anaplasma, Ehrlichia, Rickettsia. Viruses: HSV1/2, HHV6, EBV, CMV, varicella zoster, HIV, others. Wish for COVID SOT (high variance/mutations, possibly unnatural replication). Toxoplasmosis in works, not released; shows on Vibrant Tick 2.0. 50+ Borrelia species cause Lyme/TBF, not 50 SOTs needed—target big ones, balance immunity. Strep frequent on Vibrant (species level?), useful for PANS/PANDAS kids.
Babesia odocoilei: Some labs find in ticks not humans, T-Detect finds in people; SOT available.
Treat mold to baseline first ideally (screen with MSQPro, Jill Crista questionnaire; overlap with Bartonella neuro symptoms). Get load down (e.g., Itraconazole 6 months, Lipo glutathione, calcium d-glucarate, binders, herbals/prescriptions). Stable before SOT.
Concurrent: 1-hour consults cover nutrition, physical activity, stress resiliency, sleep, relationships, environment (check house; if clean but retest positive, treat systemically in sinuses/GI). Remediation stressful but often simple fixes (water leaks) radically improve health.
Avoid fight/flight, trauma; stabilize mentally/emotionally before Herx-inducing SOT—strongest physiological therapy experienced.
Want organisms replicating, not threatened/killed. RGCC protocol: Off pathogen-specific antimicrobials, antivirals, herbs, IV vitamin C, methylene blue, IV ozone, ozone insufflation 2 weeks before blood draw (for PCR detection) and 2 weeks before/after SOT administration (1 week minimum after). Provides Herx leeway; blasting post-SOT overwhelms.
Restart if feeling well, tempered by tolerance (e.g., mold patients). Antimicrobials post-SOT kill organisms, creating more dead parts that waste Pac-Man-like SOT on non-replicating debris.
Patients with mold may start at a quarter dose of binder and may not tolerate glutathione, requiring gentler alternatives. Pulling out mold too fast makes people feel sick, similar to killing bacteria or protozoa. Titrate dosing based on patient status while being aggressive within a six-month window to beat the infection while it's down. Round back with herbals and methylene blue, which has broad antibiotic coverage against Borrelia, Bartonella, Babesia, viral infections, clears COVID spike protein, and regenerates mitochondria complex 4. Photosensitize with red light therapies. Safe for six months. Sequence SOT (Supportive Oligonucleotide Therapy), then when patients feel well enough (e.g., back to running), add Cryptolepis, Japanese knotweed, phytocidal mix with Mimulonal, Cryptosynergy, and methylene blue. Retest after six months.
Do not stop antimicrobials for the specific target organism during SOT for Borrelia, Bartonella, Babesia. Let antivirals like acyclovir continue for chronic viral activation. Maintain overall immune support like vitamin D, vitamin C, as long as not directly killing Lyme (e.g., low-dose naltrexone (LDN)). LDN is beneficial for immune regulation and T-cell upregulation; all patients should be on it. No need to stop LDN before or after blood draw or SOT. Curcumin, berberine (e.g., with alkalo-gold) improve experience without killing pathogens. Killing pathogens leaves DNA/mRNA fragments, refracting the SOT like a laser through a muddy puddle, reducing benefit. Wait on those. Avoid biofilm busters immediately post-SOT to prevent pathogen overload; wait several weeks to a month or two, get other antimicrobials on board first.
Low-dose immunotherapy (LDI) from Ty Vincent's work could create immune tolerance to the microbe before SOT, minimizing mast cell activation and inflammation from dead microbes, reducing Herxheimer reactions. Colleague Dr. Andrew Peterson (past president, worked at Form Health, done thousands of SOTs) uses LDI successfully with SOT; better to ask him on integration. Speaker not trained in LDI but met Ty Vincent in medical school during Anchorage residency interest; hung out in sauna at ski resort, considers him brilliant.
Easy process, less than an hour including 250 cc bag post-SOT. Pop into IV suite; give gift certificate to Biscuit Head breakfast place next door. Make it fun: come to Asheville, stay overnight, hike, visit Biltmore. Patients feel better post-SOT due to premed dexamethasone (4 mg, low dose) for chronically inflamed/adrenal fatigue; tightens vein for systemic circulation, prevents leakage. Also IV Pepcid (or oral 6 hours before) prevents histamine reactions. No reactions in 300 SOTs except one lady with nausea (resolved with crackers/water). Family does SOT together casually; daughter (age 6) colors, familiar with Lyme. Everyone has Lyme, but not everyone sick from it. Seeing life-changing recoveries provides hope for multi-month to decade-long processes.
For headaches, fatigue, flu-like Herxheimer: use binders, detox, drainage, alkalizers weeks/months after. No RGCC blocker for remaining SOT to render inert. Be discerning; avoid in super fragile (e.g., 80-90 lb 90-year-old woman). Perque adrenal support extremely beneficial. Set up coffee enemas (make 5-6 at once like cold brew concentrate, dilute/heat to body temp for ease). Liposomal glutathione (or NAC if price issue, but NAC is biofilm buster, avoid post-SOT). Binders: Quicksilver Ultra Binder (capsule/powder, sensitive formulation), Modified citrus pectin (MCP), Z-Binder, charcoals, clays, fulvic/humic acid, chlorella. For MCAS: quercetin (e.g., Thorne Quercetinstatin 2x/day), Research Nutritionals HistAssist (histamine block, mast cell stabilize with black cumin, nettles). Anti-inflammatories: curcumin/turmeric, resolvins (SPM Active), omega, boswellia; try brands like Gaia, Thorne, Pure Encapsulations.
- 25-33%: feel better immediately (post-dexamethasone, within days).
- ~33%: flat initially (harder; track symptoms objectively with medical symptom questionnaire, Horowitz MSIDS; patients forget improvements, e.g., 34% better at 2-3 months).
- ~33%: feel worse temporarily (days to 1-2 weeks; rare month-long or couple months in advanced neurodegenerative, return to baseline but avoid in advanced cases).
EMR auto-sends forms every two days. Symptom scores drop 40-70% post-SOT; may rise at six months (repeat dose drops lower). Not one-and-done; works with detox, etc., for new homeostasis.
Borrelia afzelii (European strain, global via travel) causes nastier Herxheimer. High titers hit speaker's GI tract hard (couldn't eat 2-3 days, gas/bloating, then GI better than years). More herxing with afzelii, some Barts, Besas, B. burgdorferi.
Concept of pushing back one infection, another becomes dominant (e.g., Dr. Wayne Anderson, Dr. Eric Gordon). Post-Bartonella SOT, symptoms shift to Babesia as immune focus changes or real estate cleared. Similar to mold-fungal yeast flares. Seen clinically. Teacher Dr. Terry Bomsta (naturopath, RGCC trainer) warned of viral flares (e.g., EBV) post-Borrelia SOT. Manage holistically. Ideal: SOT for Bartonella, Babesia, Borrelia afzelii, EBV/viruses. Hard to tease Herx from specific vs. co-infection flare; likely blend.
Lasts 4-6 months, sometimes shorter. RGCC: no antimicrobials 2 weeks before, 1 week after (wastes SOT on free DNA/mRNA). Huge load reaches saturation (e.g., half-million silencing particles vs. millions of bugs).
High bacterial loads, such as 2 million versus 200,000 bugs, could lead to supersaturation and running out of medicine. The body detoxifying illegal nucleotide sequences is unclear. Basic science research on antisense oligonucleotide therapy (ASOs) shows thousands of articles; search "antisense oligonucleotides" for extensive results. RGCC website has reference pages with bench-to-bedside research and thousands of other articles. At least 10 FDA-approved drugs use this technology. Methods to stabilize oligonucleotides include phosphorothioate modifications and other ASO modifications; research papers detail these.
Unclear if SOT penetrates all body areas: blood-brain barrier, skin organisms like Bartonella or Borrelia, gastrointestinal tract lumen, low blood perfusion areas, intracellular compartments, persister cells, abscesses, dental cavitations, biofilms. Clinically, SOT reaches anywhere blood goes; personal GI effects post-SOT infusion and neurological symptom improvements in patients suggest penetration or reduced inflammatory cytokines crossing blood-brain barrier. McDonald's pathology work shows spirochetes in brains of neurodegenerative patients; tertiary syphilis also enters brain. Likely penetrates joint spaces, biofilms, abscesses, though unconfirmed; research needed, possibly in vitro.
Wait one month after SOT or until Herxheimer reaction (Herx) resolves before biofilm busters; most Herx lasts 3-4 days to 2 weeks, rarely a month. Avoid during SOT to prevent reintroducing bacteria and causing inflammatory cytokines or histamine reactions.
Hypercoagulation and fibrin accumulation precede biofilms; more common post-COVID/spike protein. Assess coagulation status and optimize blood flow for nutrient/oxygen delivery, waste removal, and SOT access to biofilm-hidden organisms. Pre-treat with lumbrokinase or nattokinase; lumbrokinase is strongest proteolytic enzyme, busts fibrin clots, biofilms, improves microcapillary circulation. Stop 1-2 weeks before SOT infusion to avoid overwhelming bacteria release, but use before blood draw to release organisms for detection. Check for systemic hypoxia, e.g., undiagnosed obstructive sleep apnea via STOP-BANG questionnaire (4-5 positive indicates likely OSA); treat with CPAP before HBOT. Lyme thrives in low oxygen; proper oxygenation aids healing.
Pulsed electromagnetic field (PEMF) mats improve microcirculation and SOT delivery. Dr. Dietrich Klinghardt uses hyaluronic acid pre-antimicrobials to draw Borrelia from tissues into blood for better access; could maximize SOT benefits.
Bell curve of responses. One-and-done example: 8-year-old boy with swollen knee, Lyme; SOT during flare, asymptomatic a year later on maintenance cryptolepis/Japanese knotweed (Cryptocompax). Ineffective extreme: Recurrent EBV flares, EBV early antigens positive post-EBV SOT; underlying moldy building suppressed immunity. Most in middle; e.g., speaker's mom with persistent Babesia/microti (PCR positive years), treated with 13-week artemether pulses, Malarone, artemisinin/cryptolepis; still positive December check despite aggressive treatment; possibly 20-year infection causing immunosuppression/cancer.
Factors: number/severity/duration of infections, co-infections. New single infection responds better than 30-year multi-infection treating one.
No SOT yet in hypermobility/EDS patients due to resources. Mold clearance reduces histamine, improves laxity (research links histamine hyperresponsiveness). Autoimmunity reverses: ANA positive (1:40-1:180) in Lyme/mold patients flips negative post-SOT/antibiotics/herbals/mold treatment; off biologics. Seen in atypical MS, symptom clusters misdiagnosed as autoimmune.
Indirect help: lowering mold eases Lyme treatment; lowering Lyme (immunosuppressant) aids mold/immune response. No direct Candida, mold, or mycotoxin SOTs.
Toxoplasma in works, likely prioritized. RGCC innovative; ask at North American conference November.
No strep SOT; Bartonella often PANS trigger. Strong recommendation against under age 5 per practitioner guide; cautionary like pregnancy contraindication. Hypothetically safe in pregnancy to prevent congenital transmission. Speaker would consider for pregnant wife or asymptomatic daughter (post-bullseye rash, doxy/azithromycin improved symptoms); tried blood draw, veins too small. Use in asymptomatic adults/kids/parents to prevent neurodegeneration (e.g., Alzheimer's); repeat every 6 months/year lifelong for high-risk (e.g., tick-exposed speaker).
Viruses use host machinery/DNA; unclear if SOT-blocked replication kills virus, allows cell survival, removes embedded virus, or requires autophagy/phagocytosis. Hypothesis: similar to immune clearance.
Indirect: LDN, methylene blue for tick infections help long COVID; treating unmasked EBV, Bartonella, Lyme improves it.
hsCRP drops dramatically post-microbe treatment. ANA negative. Low ferritin common in tick/mold (15/single digits/20s); Borrelia uses manganese, Bartonella iron, Babesia hemolyzes RBCs. Use lactoferrin (sequesters iron, immunological benefits) instead of iron in infections; levels improve.
Lactoferrin helps raise ferritin levels somewhat, but cleaning mold from the system and addressing tick infections yield the biggest benefits, with ferritin levels shooting up significantly. Clinically, patterns with SOT helping patients vary individually—some respond dramatically to Bartonella SOT (e.g., via IGeneX or Microgen), others to Lyme (Borrelia). Target the biggest infection for the most effect. Top desert island SOT: Borrelia burgdorferi, the kingpin for Dr. Bell and many patients. Treating it alone often improves everything else, as seen in Vibrant Wellness panels where only Lyme SOT was given, yet Babesia and Bartonella scores dropped because it opens the immune system.
Caveat: In severely immunosuppressed patients, initial Vibrant scores may be low-moderate; after 1-2 SOTs, retesting six months later shows dramatic score increases, indicating immune system activation—a good sign.
Dr. Andrew Peterson notes surprise at viral SOTs impacting systemic symptoms beyond local issues (e.g., HSV-1 linked to cold sores and Alzheimer's). Dr. Bell defers to Peterson, having far more experience with viral SOTs; 95% of his SOTs are tick-borne or cancer-related, <5% viral, so limited breadth there.
Retest six months after the last SOT (e.g., series ending end of March/April → October retest). Use the same lab for apples-to-apples comparison. Nuances:
- Switch to superior IGeneX if free via Medicare at age 65 (vs. cash-paid Vibrant).
- If prior full IGeneX panel negative except Bartonella FISH positive, subscale to Bartonella panel only if asymptomatic—meet patients where they're at.
Contraindications: pregnancy, breastfeeding, recent blood transfusion (wait 120 days), young children, tumor size/location (avoid brain, lungs, liver), advanced neurodegenerative conditions (relative), fragile health (relative). Social: isolated patients with poor tech access/social support in telemedicine (Dr. Bell covers TX, CO, FL, NC, TN, SC, GA)—may forgo SOT due to Herxheimer risk without quick follow-up.
Few incompatibilities; independent of immune system. Steroid injections or IVIG not highlighted as issues beyond listed.
- Own misses: check for mold, proper testing (e.g., don't skimp—IGeneX $2,000 ROI phenomenal vs. cheaper Vibrant $550-600 missing key infections). Scarcity mentality from Haiti mission work leads to paternalism, hurting patients.
- Unaddressed factors: mold in house, etc.
- Perpetual sympathetic overdrive/trauma (little T or big T)—not conducive to healing regardless of therapies; needs deep internal consciousness/soul-level shift. Dr. Bell experienced depression himself.
Available throughout US via RGCC provider map (filter by SOT/cancer testing); all 50 states including AK. Most European countries, but last year EU political issues (e.g., Poland?) temporarily withheld—patients traveled elsewhere; status unclear, likely political not safety.
Not FDA approved—personalized advanced biological molecular product like autologous stem cells/PRP, bypasses FDA (EU Medicines Union covers; RGCC GMP/CLIA certified).
Costs: $2,000-$3,500 per SOT (varies by overhead). Dr. Bell's telemedicine model (no brick-and-mortar, advanced practitioners, nurse for infusions): $2,200 (low end, underpriced logistically). Expect ~$2,500 fair average; $3,000 not overcharging. Excludes testing, appointments (independent; decide SOT appropriateness there), blood draw, infusion, RGCC fee.
Exercise and nature: cerebral Gemini always problem-solving—turns off phone for weekly mountain bike in woods/forest. Daily workouts prevent depression; moving body shifts energy from cerebral cortex.
Self-care constant practice (hard with kids/partner); providers/patients often neglect it while caring for others—why would body heal?
www.metamme. MetaM.life (metamed.life) to reach out.
Keep BetterHealthGuy in your library
Save the videos and channels worth coming back to, and find them again in one place.
